Cipla Ltd.

Cipla is going to price its generic version of antiviral drug remdesivir at less than Rs 5,000 per vial in keeping with its conviction of providing access to the medicines at affordable cost. The drug will be priced at less than Rs 5,000 per vial for injection 100 mg -- amongst the lowest pricing for remdesivir globally.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.